Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1063 | 1062 | 1173 | 1307 | 1712 | 2478 |
Fund Return | 6.34% | 6.23% | 17.29% | 9.34% | 11.35% | 9.5% |
Place in category | 154 | 139 | 36 | 51 | 48 | 57 |
% in Category | 21 | 19 | 5 | 10 | 7 | 15 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
S Horizon Global Technology Fund Ag | 20.04M | 16.08 | 9.80 | 19.18 | ||
S Horizon Global Technology Fund 1g | 2.72M | 16.43 | 10.76 | 20.22 | ||
S Horizon Global Technology Fund Hg | 6.66M | 13.85 | 12.16 | 19.04 | ||
Janus Global Life Sciences Fund U G | 3.96B | 7.74 | 9.50 | 13.38 | ||
Opportunities Fund I Inc | 43.33M | 6.25 | 9.04 | 9.19 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
iShares Continental Europe Eq D Acc | 6.34B | 5.28 | 7.35 | 8.27 | ||
GB00BJL5BS14 | 6.34B | 5.28 | 7.36 | 8.28 | ||
Continental European Flexible Fundg | 5.81M | 8.63 | 5.62 | 12.35 | ||
European Dynamic Fund A Accumulatio | 4.59B | 7.98 | 4.27 | 10.73 | ||
European Dynamic Fund A Income | 4.59B | 7.98 | 4.27 | 10.72 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 6.37 | 909.9 | +3.02% | |
ASML Holding | NL0010273215 | 5.72 | 853.00 | -1.33% | |
SAP | DE0007164600 | 4.04 | 176.680 | +0.35% | |
Louis Vuitton | FR0000121014 | 3.80 | 782.60 | -0.74% | |
Safran | FR0000073272 | 3.65 | 209.50 | -1.41% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review